Coho Partners Ltd. decreased its holdings in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 38.2% during the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 206,953 shares of the company's stock after selling 128,091 shares during the quarter. Coho Partners Ltd.'s holdings in Kenvue were worth $4,963,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently modified their holdings of the business. Fulton Bank N.A. grew its holdings in Kenvue by 0.6% during the 1st quarter. Fulton Bank N.A. now owns 78,888 shares of the company's stock worth $1,892,000 after acquiring an additional 465 shares in the last quarter. Deseret Mutual Benefit Administrators grew its holdings in Kenvue by 29.0% during the 4th quarter. Deseret Mutual Benefit Administrators now owns 2,528 shares of the company's stock worth $54,000 after acquiring an additional 568 shares in the last quarter. SRS Capital Advisors Inc. grew its holdings in Kenvue by 67.4% during the 4th quarter. SRS Capital Advisors Inc. now owns 1,418 shares of the company's stock worth $30,000 after acquiring an additional 571 shares in the last quarter. Keystone Financial Group grew its holdings in Kenvue by 4.8% during the 4th quarter. Keystone Financial Group now owns 12,736 shares of the company's stock worth $272,000 after acquiring an additional 578 shares in the last quarter. Finally, First Horizon Advisors Inc. grew its holdings in Kenvue by 2.4% during the 4th quarter. First Horizon Advisors Inc. now owns 25,047 shares of the company's stock worth $535,000 after acquiring an additional 580 shares in the last quarter. Institutional investors own 97.64% of the company's stock.
Analyst Ratings Changes
Several brokerages have issued reports on KVUE. Citigroup reiterated a "neutral" rating on shares of Kenvue in a report on Friday, June 13th. Barclays increased their target price on shares of Kenvue from $22.00 to $23.00 and gave the stock an "equal weight" rating in a report on Monday, May 12th. UBS Group increased their price target on shares of Kenvue from $24.00 to $25.00 and gave the company a "neutral" rating in a research report on Friday, May 9th. Redburn Atlantic assumed coverage on shares of Kenvue in a research report on Thursday, April 10th. They set a "neutral" rating and a $23.50 price target for the company. Finally, Piper Sandler increased their price target on shares of Kenvue from $24.00 to $27.00 and gave the company an "overweight" rating in a research report on Monday, February 24th. Seven equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to data from MarketBeat, Kenvue currently has an average rating of "Hold" and a consensus target price of $25.33.
Check Out Our Latest Research Report on KVUE
Kenvue Stock Performance
Shares of Kenvue stock opened at $21.39 on Friday. The firm has a market capitalization of $41.03 billion, a P/E ratio of 38.88, a PEG ratio of 3.32 and a beta of 0.98. The company has a quick ratio of 0.60, a current ratio of 0.86 and a debt-to-equity ratio of 0.63. The company has a 50 day moving average price of $22.99 and a 200 day moving average price of $22.41. Kenvue Inc. has a 52 week low of $17.67 and a 52 week high of $25.17.
Kenvue (NYSE:KVUE - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The company reported $0.24 EPS for the quarter, beating the consensus estimate of $0.23 by $0.01. The firm had revenue of $3.74 billion during the quarter, compared to analyst estimates of $3.69 billion. Kenvue had a net margin of 6.90% and a return on equity of 20.87%. Kenvue's revenue was down 3.9% on a year-over-year basis. During the same period last year, the firm posted $0.28 EPS. Sell-side analysts expect that Kenvue Inc. will post 1.14 EPS for the current year.
Kenvue Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, May 28th. Investors of record on Wednesday, May 14th were given a $0.205 dividend. This represents a $0.82 annualized dividend and a dividend yield of 3.83%. The ex-dividend date was Wednesday, May 14th. Kenvue's payout ratio is currently 149.09%.
Kenvue Profile
(
Free Report)
Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Kenvue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kenvue wasn't on the list.
While Kenvue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
